Appili Therapeutics (APLIF) Earnings Date, Estimates & Call Transcripts

$0.03
0.00 (0.00%)
(As of 04/24/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Jun. 21Estimated
Actual EPS
(Feb. 13)
-$0.01
Consensus EPS
(Feb. 13)
-$0.01
Skip Charts & View Estimated and Actual Earnings Data

APLIF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

APLIF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Appili Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.02)($0.02)($0.02)
Q2 20241($0.01)($0.01)($0.01)
Q3 20241($0.01)($0.01)($0.01)
Q4 20241($0.01)($0.01)($0.01)
FY 20244($0.05)($0.05)($0.05)

APLIF Earnings Date and Information

Appili Therapeutics last released its quarterly earnings results on February 13th, 2024. The reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01). The company earned $0.36 million during the quarter. Appili Therapeutics has generated ($0.04) earnings per share over the last year (($0.04) diluted earnings per share). Earnings for Appili Therapeutics are expected to remain at ($0.04) per share in the coming year. Appili Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 21st, 2024 based off prior year's report dates.

Appili Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
6/21/2024
Estimated)
------- 
2/13/2024Q3 2024($0.01)($0.01)---$0.36 million
11/13/2023Q2 2024($0.01)($0.01)-($0.01)-$0.25 million    
8/11/2023Q1 2024($0.02)($0.01)+$0.01($0.01)-$0.01 million
6/23/2023Q4 2023-($0.02)($0.02)($0.02)-$0.25 million    
2/14/2023Q3 2023($0.02)($0.02)-($0.02)-$0.01 million
11/10/2022Q2 2023($0.02)($0.01)+$0.01($0.01)-$0.01 million
8/12/2022Q1 2023($0.02)($0.02)-($0.02)--
6/29/2022Q4 2022($0.08)($0.06)+$0.02($0.06)--
2/14/2022Q3 2022($0.07)($0.04)+$0.03($0.04)-$1.11 million
11/12/2021Q2 2022($0.07)($0.14)($0.07)($0.14)--
8/13/2021Q1 2022($0.06)($0.10)($0.04)($0.10)-$0.01 million
6/24/2021Q4 2021-($0.06)($0.06)($0.06)-$0.02 million

Appili Therapeutics Earnings - Frequently Asked Questions

When is Appili Therapeutics's earnings date?

Appili Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 21st, 2024 based off last year's report dates. Learn more on APLIF's earnings history.

Did Appili Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Appili Therapeutics (OTCMKTS:APLIF) reported ($0.01) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.01). Learn more on analysts' earnings estimate vs. APLIF's actual earnings.

How much revenue does Appili Therapeutics generate each year?

Appili Therapeutics (OTCMKTS:APLIF) has a recorded annual revenue of $280,000.00.

How much profit does Appili Therapeutics generate each year?

Appili Therapeutics (OTCMKTS:APLIF) has a recorded net income of -$6.99 million. APLIF has generated -$0.04 earnings per share over the last four quarters.

What is Appili Therapeutics's EPS forecast for next year?

Appili Therapeutics's earnings are expected to stay at ($0.04) per share in the next year.


More Earnings Resources from MarketBeat

This page (OTCMKTS:APLIF) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners